• Press Release

Mount Sinai Health System Celebrates Heart Month

  • New York
  • (January 25, 2018)

In honor of American Heart Month in February, the Mount Sinai Health System will host several “Go Red" Community Heart Health Fairs throughout its system. These events will provide free heart health screenings for blood pressure, cholesterol, triglyceride, and body mass index (BMI), as well as educational demonstrations and talks on nutrition and diet, diabetes, stress management, smoking cessation, yoga and other relaxation techniques by Mount Sinai experts.

"Our goal this Heart Month is to educate our communities and employees about the risk factors for cardiovascular disease, the number one killer of Americans," said Beth Oliver, RN, DNP, Senior Vice President of Cardiac Services for the Mount Sinai Health System. "By incorporating health screenings and educational demonstrations in our Heart Month events, we aim to empower attendees to take control of their heart health and make positive, healthy changes."

Heart disease is also the number one killer of women, causing one in three deaths each year, according to the American Heart Association. That’s approximately one woman every minute. To raise awareness of this issue that affects millions of women and families, the American Heart Association (AHA) launched Go Red for Women in 2004. The initiative challenges women to know their risk for heart disease and take action to reduce it. Event attendees are encouraged to wear anything red—from a red accessory to full red attire—to remind women about the proportionately greater risk they face for cardiovascular disease and heart attacks. Women can take action to improve their overall health by making a few lifestyle changes such as lowering their cholesterol, managing their blood sugar, exercising, and eating healthy.

For more information, please visit mountsinai.org/GoRed.

"Go Red" Community Heart Health Fairs will be held on Friday, February 2, 2018 from 11 a.m. to 2 p.m. at the following locations:

The Mount Sinai Hospital
1468 Madison Avenue
Guggenheim Pavilion, Lobby
Contact: Dion Harrigan 212-241-6146

Mount Sinai Union Square
10 Union Square East
Second Floor–Atrium
Contact: Lena Chang 212-420-4746

Mount Sinai St. Luke's
1111 Amsterdam Avenue at 114th Street
Babcock Lobby, First Floor
Contact: Joan Joseph 212-523-2023

Mount Sinai West
1000 Tenth Avenue at West 58th Street
Main Lobby
Contact: Wendy O’Brien 646-745-5725

Mount Sinai Queens (Event runs from 4 pm-6 pm)
Ambulatory Pavilion
25-20 30th Avenue, Fifth Floor
Contact: Ana Rodriquez 718-808-7726


About the Mount Sinai Health System

Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.

As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.

Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek® and No. 7 in the U.S. on the magazine’s 2026 World’s Best Hospitals list and No. 3 in the world in its World’s Best Smart Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 9 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health grant funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.